BODENSTEDT MATTHIAS (Chief Financial Officer) sold 1.2% of their position (13.65K shares) of MOONLAKE IMMUNOTHERAPEUTICS on the open market
Open‑market sale worth $273.3K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/13/2026ACC: 0001213900-26-055799
Officer· Chief Financial Officer
Since Apr 2022
-13.65K
Net shares
Net seller
$273.3K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
13.65K disposed
Non-Derivative Transactions1
Class A ordinary shares, par value $0.0001 per share
Direct
Shares
−13.65K
Price / share
$20.02
Trade value
$273.33K
% of position
1.2%
5/11/2026
1.19M→1.17M
Total
Net shares
−13.65K
Net value
-$273.33K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A ordinary shares, par value $0.0001 per share Direct | 5/11/2026 | S · Sale | −13.65K | $20.02 | $273.33K | 1.2% | 1.19M | 1.17M |
| Total | −13.65K | -$273.33K | ||||||
Derivative Transactions0
No derivative transactions reported